放射治疗中的核酸药物
Yuying Yang1,2, Cai Yang2,3, Kai Deng1,2
1College of Pharmaceutical Sciences, Zhejiang University of Technology, Hangzhou, 310014, China.
核酸药物 (NADs) 通过改善瘤向和克服耐药性来增强癌症放射治疗. 这篇评论探讨了NADs.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 辐射疗法 辐射疗法
背景情况:
- 放射治疗是一种关键的癌症治疗方法,它使用辐射杀死瘤细胞.
- 诸如抗辐射和副作用等挑战限制了放射治疗的有效性.
- 核酸药物 (NAD) 为克服这些局限性提供了一种新的方法.
研究的目的:
- 审查核酸药物 (NAD) 在优化癌症放射治疗中的作用.
- 探索NADs与放射治疗的机制,临床应用和协同潜力.
- 突出NADs作为改善癌症治疗结果的有希望的战略.
主要方法:
- 对核酸药物和放射治疗研究的文献综述.
- 针对DNA修复和瘤缺氧的NADs机制的分析.
- 对NADs作为放射治疗剂的输送载体的检查.
- 探索临床应用和协同效应.
主要成果:
- 通过向关键癌症途径,NAD可以增强放射治疗的敏感性.
- NADs可以作为放射性核酸的输送系统,提高精度和减少副作用.
- NADs在克服辐射抵抗方面表现出潜力.
结论:
- 核酸药物显示显著增强放射治疗疗效的承诺.
- NADs为改善癌症治疗结果提供了一种多功能策略.
- 对NADs临床应用的进一步研究是有必要的.
更多相关视频
09:04Sequence-specific and Selective Recognition of Double-stranded RNAs over Single-stranded RNAs by Chemically Modified Peptide Nucleic Acids
Published on: September 21, 2017
11:58Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
Published on: March 8, 2018
相关概念视频
Targeted Cancer Therapies
There are several types of targeted therapies against...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
Drugs that Stabilize Microtubules
Drugs that Destabilize Microtubules
